logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
P

Paul Arora

university of toronto

28H指数
131论文数
3.5K被引数
收录论文 50
发表时间
logo
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 26我们准备好报销了吗？健康技术评估相关真实世界证据的发展综述：第26部分
errJournal of Comparative Effectiveness Research
IF2.5
err2026-07-01
err0
PREAI
errArora, Paul; Ramagopalan, Sreeram, V
err分享
err收藏
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25我们准备好报销了吗？与卫生技术评估相关的真实世界证据发展综述：第25部分
errJournal of Comparative Effectiveness Research
IF2.5
err2026-06-01
err1
PREAI
errArora, Paul; Ramagopalan, Sreeram, V
err分享
err收藏
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 24我们准备好报销了吗？健康技术评估相关真实世界证据的发展概述：第24部分
errJournal of Comparative Effectiveness Research
IF2.5
err2026-02-01
err1
PREAI
errArora, Paul; Ramagopalan, Sreeram, V
err分享
err收藏
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 23我们准备好报销了吗？与卫生技术评估相关的真实世界证据发展综述：第23部分
errJournal of Comparative Effectiveness Research
IF2.5
err2026-01-01
err0
PREAI
errArora, Paul; Ramagopalan, Sreeram, V
err分享
err收藏
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 21我们准备好进行报销了吗？健康技术评估相关真实世界证据的发展综述：第21部分
errJournal of Comparative Effectiveness Research
IF2.5
err2025-10-01
err0
errOAAI
errArora, Paul; Ramagopalan, Sreeram, V
err分享
err收藏
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 22我们准备好进行报销了吗？关于与卫生技术评估相关的真实世界证据的最新进展综述：第22部分
errJournal of Comparative Effectiveness Research
IF2.5
err2025-10-01
err0
PREAI
errArora, Paul; Ramagopalan, Sreeram, V
err分享
err收藏
Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study真实世界生存结局、治疗模式及PD-L1表达对加拿大接受CRT→度伐利尤单抗治疗的不可切除、Ⅲ期NSCLC患者的影响：RELEVANCE研究
errLUNG CANCER
IF4.4
err2025-06-01
err0
errOAAI
errWheatley-Price, Paul; Navani, Vishal; Pabani, Aliyah; Routy, Bertrand; Snow, Stephanie; Denault, Marie-Helene; Kim, YongJin; Syed, Iqra; Devost, Natalie; Hui, Daphne; Qadeer, Rana A.; Arora, Paul; Velummailum, Russanthy; Springford, Aaron; McKibbon, Chelsea; Ho, Cheryl
err分享
err收藏
Quantitative Bias Analysis for Single-Arm Trials With External Control Arms单臂试验的外部对照臂定量偏倚分析
errJAMA NETWORK OPEN
IF9.7
err2025-03-26
err0
errOAAI
errGupta, Alind; Hsu, Grace; Kent, Seamus; Duffield, Stephen J.; Merinopoulou, Evie; Lockhart, Alexandre; Arora, Paul; Ray, Joshua; Wilkinson, Samantha; Scheuer, Nicolas; Ramagopalan, Sreeram V.; Groenwold, Rolf H. H.; Popat, Sanjay; Hernan, Miguel A.
err分享
err收藏
The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States
errVALUE IN HEALTH
IF6
err2024-08-01
err0
PREAI
errArora, Paul; Gupta, Alind; Mackay, Emma; Heeg, Bart; Thorlund, Kristian
err分享
err收藏
Association between treatment and improvements in overall survival of patients with advanced/metastatic non-small cell lung cancer since 2011: A study in the United States, Canada, and Germany using retrospective real-world databases
errCANCER
IF5.1
err2023-11-07
err0
errOAAI
errGriesinger, Frank; Ramagopalan, Sreeram; Cheung, Winson Y.; Wilke, Thomas; Mueller, Sabrina; Gupta, Alind; O'Sullivan, Dylan E.; Arora, Paul; Brenner, Darren R.; Froelich, Carolin; Inskip, Jessica; Maywald, Ulf; Subbiah, Vivek
err分享
err收藏
Early Treatment with Pegylated Interferon Lambda for Covid-19
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2023-02-09
err107
errOAAI
errReis, Gilmar; Moreira Silva, Eduardo A. S.; Medeiros Silva, Daniela C.; Thabane, Lehana; Campos, Vitoria H. S.; Ferreira, Thiago S.; Santos, Castilho V. Q.; Nogueira, Ana M. R.; Almeida, Ana P. F. G.; Savassi, Leonardo C. M.; Figueiredo-Neto, Adhemar D.; Dias, Ana C. F.; Freire Junior, Adelino M.; Bitares, Carina; Milagres, Aline C.; Callegari, Eduardo D.; Simplicio, Maria I. C.; Ribeiro, Luciene B.; Oliveira, Rosemary; Harari, Ofir; Wilson, Lindsay A.; Forrest, Jamie I.; Ruton, Hinda; Sprague, Sheila; McKay, Paula; Guo, Christina M.; Limbrick-Oldfield, Eve H.; Kanters, Steve; Guyatt, Gordon H.; Rayner, Craig R.; Kandel, Christopher; Biondi, Mia J.; Kozak, Robert; Hansen, Bettina; Zahoor, M. Atif; Arora, Paul; Hislop, Colin; Choong, Ingrid; Feld, Jordan J.; Mills, Edward J.; Glenn, Jeffrey S.
err分享
err收藏
Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world dataFOLFIRINOX与吉西他滨联合nab-紫杉醇在晚期胰腺癌中的头对头比较: 使用真实数据的目标试验模拟
errANNALS OF EPIDEMIOLOGY
IF3
err2023-02-01
err7
PREAI
errBoyne, Devon J.; Brenner, Darren R.; Gupta, Alind; Mackay, Eric; Arora, Paul; Wasiak, Radek; Cheung, Winson Y.; Hernan, Miguel A.
err分享
err收藏
Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma
errJCO CLINICAL CANCER INFORMATICS
IF2.8
err2021-12-01
err3
errOAAI
errGupta, Alind; Arora, Paul; Brenner, Darren; Vanderpuye-Orgle, Jacqueline; Boyne, Devon J.; Edmondson-Jones, Mark; Parkhomenko, Elena; Stevens, Warren; Dudani, Shaan; Heng, Daniel Y. C.; Wagner, Samuel; Borrill, John; Wu, Elise
err分享
err收藏
Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer
errJAMA NETWORK OPEN
IF9.7
err2021-11-12
err14
errOAAI
errRamagopalan, Sreeram; Gupta, Alind; Arora, Paul; Thorlund, Kristian; Ray, Joshua; Subbiah, Vivek
err分享
err收藏
Assessment of Alectinib vs Ceritinib in ALK-Positive Non-Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data
errJAMA NETWORK OPEN
IF9.7
err2021-10-07
err17
errOAAI
errWilkinson, Samantha; Gupta, Alind; Scheuer, Nicolas; Mackay, Eric; Arora, Paul; Thorlund, Kristian; Wasiak, Radek; Ray, Joshua; Ramagopalan, Sreeram; Subbiah, Vivek
err分享
err收藏
Comparative effectiveness of atezolizumab (Atz) versus docetaxel (Dtx) or nivolumab (Niv) in previously treated (pt) patients with advanced non-small cell lung cancer (aNSCLC): A US real-world (RW) study
errANNALS OF ONCOLOGY
IF65.4
err2021-09-01
err0
errOAAI
errSubbiah, V.; Gupta, A.; Ray, J.; Arora, P.; Thorlund, K.; Ramagopalan, S.
err分享
err收藏
Stability of diagnostic rate in a cohort of 38,813 colorectal polyp specimens and implications for histomorphology and statistical process control
errSCIENTIFIC REPORTS
IF3.9
err2021-08-20
err4
errOAAI
errBonert, Michael; Naqvi, Asghar; Rahman, Mozibur; Marshall, John K.; Xenodemetropoulos, Ted; Arora, Paul; Slater, Justin; Major, Pierre
err分享
err收藏
PRIME-IPD SERIES Part 1. The PRIME-IPD tool promoted verification and standardization of study datasets retrieved for IPD meta-analysis
errJOURNAL OF CLINICAL EPIDEMIOLOGY
IF5.2
err2021-08-01
err8
PREAI
errDewidar, Omar; Riddle, Alison; Ghogomu, Elizabeth; Hossain, Alomgir; Arora, Paul; Bhutta, Zulfiqar A.; Black, Robert E.; Cousens, Simon; Gaffey, Michelle F.; Mathew, Christine; Trawin, Jessica; Tugwell, Peter; Welch, Vivian; Wells, George A.
err分享
err收藏
PRIME-IPD SERIES Part 3. The PRIME-IPD tool fills a gap in guidance for preparing IPD for analysis
errJOURNAL OF CLINICAL EPIDEMIOLOGY
IF5.2
err2021-08-01
err1
errOAAI
errDewidar, Omar; Riddle, Alison; Ghogomu, Elizabeth; Hossain, Alomgir; Arora, Paul; Bhutta, Zulfiqar A.; Black, Robert E.; Cousens, Simon; Mathew, Christine; Trawin, Jessica; Tugwell, Peter; Welch, Vivian; Wells, George A.
err分享
err收藏
Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma A Systematic Review and Meta-analysis
errJAMA NETWORK OPEN
IF9.7
err2021-01-26
err7
errOAAI
errSati, Neha; Boyne, Devon J.; Cheung, Winson Y.; Cash, Sarah B.; Arora, Paul
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
G
Gordon Guyatt
H 指数: 256 · 论文数: 2.2K
J
John P. A. Ioannidis
H 指数: 226 · 论文数: 1.9K
D
David Moher
H 指数: 214 · 论文数: 1.5K
Z
Zulfiqar A Bhutta
H 指数: 214 · 论文数: 1.9K
G
George A. Wells
H 指数: 164 · 论文数: 1.3K
查看更多